Product
Coronavirus-specific T cell
1 clinical trial
1 indication
Indication
COVID-19Clinical trial
T CELL THERAPY OPPOSING NOVEL COVID-19 INFECTION IN IMMUNOCOMPROMISED PATIENTSStatus: Recruiting, Estimated PCD: 2025-11-01
1 clinical trial
1 indication